Cargando…
Partial Inhibition of mTORC1 in Aged Rats Counteracts the Decline in Muscle Mass and Reverses Molecular Signaling Associated with Sarcopenia
There is a lack of pharmacological interventions available for sarcopenia, a progressive age-associated loss of muscle mass, leading to a decline in mobility and quality of life. We found mTORC1 (mammalian target of rapamycin complex 1), a well-established positive modulator of muscle mass, to be su...
Autores principales: | Joseph, Giselle A., Wang, Sharon X., Jacobs, Cody E., Zhou, Weihua, Kimble, Garrett C., Tse, Herman W., Eash, John K., Shavlakadze, Tea, Glass, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751631/ https://www.ncbi.nlm.nih.gov/pubmed/31308131 http://dx.doi.org/10.1128/MCB.00141-19 |
Ejemplares similares
-
Short-term Low-Dose mTORC1 Inhibition in Aged Rats Counter-Regulates Age-Related Gene Changes and Blocks Age-Related Kidney Pathology
por: Shavlakadze, Tea, et al.
Publicado: (2018) -
TLR4 counteracts BVRA signaling in human leukocytes via differential regulation of AMPK, mTORC1 and mTORC2
por: Zhang, Zhiyong, et al.
Publicado: (2019) -
Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication
por: Carter, Christoph C., et al.
Publicado: (2022) -
The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia
por: Ham, Daniel J., et al.
Publicado: (2020) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)